Trademark Overview
On Wednesday, October 8, 2025, a trademark application was filed for EINDURA with the United States Patent and Trademark Office. The USPTO has given the EINDURA trademark a serial number of 99433753. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 8, 2025. This trademark is owned by Eindura Therapeutics, Inc.. The EINDURA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biologics in the nature of cells for medical use, namely, covalent protein biologics; synthetic biology enabled covalent therapeutics and covalent peptide drugs and covalent protein drugs for the treatment of cancer, immune and inflammatory conditions, and metabolic diseases and disorders; libraries of covalent protein drugs and covalent peptide drugs for the treatment of cancer, immune and inflammatory conditions, and metabolic diseases and disorders; covalent antibodies for medical purposes
Research and development in the field of covalent protein biologics; research and development of synthetic peptides containing covalent activation; research and development in the field of synthetic biology enabled covalent therapeutics and covalent peptide drugs and protein drugs; research and development for the purpose of selective covalent modification of peptides and proteins; research and development in the field of covalent protein drugs, namely, development of a platform technology for identification of covalent binding small-molecule and biologic therapeutics; research and development services for the purpose of engineering covalent antibodies
